Recruiting a representative patient population remains one of the most persistent challenges in clinical research.
Barriers including cost, transportation, and health literacy drive low participation and dropout rates, and with the FDA now requiring Diversity Action Plans for Phase III trials, embedding community-led engagement into trial design from the outset is more important than ever. Achieving this requires more than outreach. It means identifying diverse patient populations early, making smarter site selection decisions, and deploying the right tools and partnerships to recruit at pace without sacrificing representation.
Join this 60-minute live webinar with senior clinical research leaders to build the practical tools and frameworks needed to:
- Identify and map diverse patient populations early in trial design to inform protocol development, eligibility criteria, and site selection decisions
- Select sites based on their proximity to, and established relationships with, target patient communities to accelerate recruitment and improve representation
- Build partnerships with local organizations, advocacy groups, and community leaders to generate trust, drive referrals, and reduce the barriers that slow recruitment
Tune in to learn how smarter population identification, data-driven site selection, and community-centered recruitment strategies can accelerate timelines, improve diversity representation, and deliver trials that are truly built for the patients they aim to serve.
Can’t make the live session? Register to receive the session recording straight to your inbox.
